Tempus AI Total Current Liabilities 2023-2025 | TEM

Tempus AI total current liabilities from 2023 to 2025. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
  • Tempus AI total current liabilities for the quarter ending March 31, 2025 were $0.336B, a 60.59% increase year-over-year.
  • Tempus AI total current liabilities for 2024 were $0.291B, a 25.12% increase from 2023.
  • Tempus AI total current liabilities for 2023 were $0.233B, a 33.51% increase from 2022.
  • Tempus AI total current liabilities for 2022 were $0.174B, a 0% decline from .
Tempus AI Annual Total Current Liabilities
(Millions of US $)
2024 $291
2023 $233
2022 $174
Tempus AI Quarterly Total Current Liabilities
(Millions of US $)
2025-03-31 $336
2024-12-31 $291
2024-09-30 $253
2024-06-30 $182
2024-03-31 $210
2023-12-31 $233
2023-09-30
2023-06-30
2023-03-31
2022-12-31 $174
Sector Industry Market Cap Revenue
Medical Medical Information Systems $9.847B $0.693B
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $45.084B 57.36
Doximity (DOCS) United States $11.307B 52.35
Hims & Hers Health (HIMS) United States $10.719B 111.37
IRhythm Technologies (IRTC) United States $4.340B 0.00
Inspire Medical Systems (INSP) United States $3.842B 60.03
Hinge Health (HNGE) United States $3.717B 0.00
Privia Health (PRVA) United States $2.496B 170.58
Enovis (ENOV) United States $1.944B 10.84
Phreesia (PHR) United States $1.590B 0.00
10x Genomics (TXG) United States $1.576B 0.00
Schrodinger (SDGR) United States $1.542B 0.00
Azenta (AZTA) United States $1.532B 71.21
Clover Health Investments (CLOV) United States $1.486B 0.00
Omnicell (OMCL) United States $1.344B 23.71
Evolent Health (EVH) United States $1.313B 111.80
Claritev (CTEV) United States $0.761B 0.00
Fulgent Genetics (FLGT) United States $0.587B 0.00
Veradigm (MDRX) United States $0.547B 0.00
Standard BioTools (LAB) United States $0.501B 0.00
Butterfly Network (BFLY) United States $0.448B 0.00
Talkspace (TALK) United States $0.442B 132.00
Outset Medical (OM) United States $0.344B 0.00
TruBridge (TBRG) United States $0.331B 735.33
Health Catalyst (HCAT) United States $0.271B 0.00
Nyxoah SA (NYXH) Belgium $0.258B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.233B 0.00
CapsoVision (CV) United States $0.212B 0.00
KORU Medical Systems (KRMD) United States $0.161B 0.00
Zepp Health (ZEPP) Netherlands $0.150B 0.00
American Well (AMWL) United States $0.131B 0.00
EUDA Health Holdings (EUDA) Singapore $0.123B 0.00
Pulmonx (LUNG) United States $0.117B 0.00
MDxHealth SA (MDXH) Belgium $0.103B 0.00
CareCloud (CCLD) United States $0.101B 3.84
Insight Molecular Diagnostics (IMDX) United States $0.082B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.068B 0.00
111 (YI) China $0.065B 0.00
P3 Health Partners (PIII) United States $0.045B 0.00
HeartBeam (BEAT) United States $0.042B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
Precipio (PRPO) United States $0.024B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Bullfrog AI Holdings (BFRG) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Healthcare Triangle (HCTI) United States $0.009B 0.00
MSP Recovery (MSPR) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.005B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00